Genome Editing Consortium Workshop

Description

The NIST Genome Editing Consortium addresses the measurements and standards needed to increase confidence and lower the risk of utilizing genome editing technologies in research and commercial products and consists of members across federal, academic, and private organizations. Visit site for full list of public workshop sessions.

Powerful Sequencing Tool Helps Identify Infectious Diseases in Mali

NIAID Now |

Powerful Sequencing Tool Helps Identify Infectious Diseases in Mali

An advanced diagnostic tool used in an observational clinical study in Bamako, Mali, helped identify infectious viruses in hospital patients that normally would have required many traditional tests. Scientists, led by the National Institute of Allergy and Infectious Diseases (NIAID), designed the study to help physicians identify the causes of unexplained fever in patients and to bring awareness to new technology in a resource-limited region.

Because malaria is the most common fever-causing illness in rural sub-Saharan Africa, most medical workers in the region presume patients with a fever have malaria. But recent NIAID work has identified dengue, Zika and chikungunya viruses – like malaria, all spread by mosquitos – in some Malian residents.

The observational study of 108 patients, published recently in The American Journal of Tropical Medicine and Hygiene, added the advanced diagnostic test, known as VirCapSeq-VERT, to traditional testing methods to identify cases of measles, SARS-CoV-2, HIV, and other viral diseases in patients. Surprisingly, more than 40% of patients were found to have more than one infection.

VirCapSeq-VERT is the virome capture-sequencing platform for vertebrate viruses, a powerful DNA sequencing technique capable of finding all viruses known to infect humans and animals in specimens, such as plasma. VirCapSeq-VERT uses special probes that capture all virus DNA and RNA in a specimen, even if the researcher does not know which specific virus to look for. Scientists then sequence the captured DNA and RNA to identify viruses present to solve the mystery of which viral infection(s) a patient has.

In the study, the researchers recommend that combining VirCapSeq-VERT with traditional diagnostic tests could greatly assist physicians “in settings with large disease burdens or high rates of coinfections and may lead to better outcomes for patients.”

Scientists from NIAID’s Division of Clinical Research collaborated on the project from July 2020 to October 2022 with colleagues from the University of Sciences, Techniques, and Technologies of Bamako, Mali, and Columbia University.

Reference: A Koné, et al. Adding Virome Capture Metagenomic Sequencing to Conventional Laboratory Testing Increases Unknown Fever Etiology Determination in Bamako, Mali. The American Journal of Tropical Medicine and Hygiene DOI: https://doi.org/10.4269/ajtmh.24-0449 (2024).

Contact Information

Contact the NIAID Media Team.

301-402-1663
niaidnews@niaid.nih.gov

Search NIAID Blog

NIH Officials Assess Threat of H5N1

HPAI H5N1 influenza remains a low risk to most Americans, but that does not diminish concern about the virus, NIAID experts say.

Contact

Submit a Media Request

Contact the NIAID News & Science Writing Branch.

301-402-1663
niaidnews@niaid.nih.gov
All Media Contacts

Research fields, such as genomics, proteomics, and systems biology, are creating a wealth of information about infectious and immune-mediated diseases. Through the use of advanced technologies, researchers are developing a clearer understanding of pathogens, disease, and host immunity.

Advanced technologies research fields, such as genomics, proteomics, and bioinformatics, hold great promise for developing new diagnostics, therapeutics, and vaccines to treat and prevent infectious and immune-mediated diseases.

NIAID has made a significant commitment to support and encourage advanced technologies research in Institute labs and in the scientific community. Sophisticated tools are being used to determine the genetic make-up of disease-causing pathogens, to analyze discrepancies among pathogen strains, and to evaluate how immune system responses differ.

A close-up image (gloved hand and test tube) of scientist studying varicella zoster virus (VZV), the cause of chickenpox and shingles.

Varicella zoster virus DNA study in the NIAID Laboratory of Clinical Investigation's medical virology laboratory.

Credit: NIAID

Genomic Sequences

NIAID-supported researchers have completed hundreds of genomic sequences of disease-causing organisms, including pathogens responsible for malaria, tuberculosis, chlamydia, and seasonal and pandemic influenza. Recently, the NIAID-supported Structural Genomics Centers for Infectious Diseases accomplished a significant milestone by determining their 200th 3-D protein structure, information that could provide researchers with critical knowledge for the development of new treatment and prevention strategies.

Data Sharing

Data generated through NIAID-supported initiatives is being made rapidly available to the research community. The ultimate goal of the NIAID genomics and advanced technologies program is that researchers will use these data to further pursue new discoveries about the causes, treatment, and ultimate prevention of infectious and immune-mediated diseases.

Genomics Advanced Technologies
Page Summary
Research fields, such as genomics, proteomics, and systems biology, are creating a wealth of information about infectious and immune-mediated diseases. Through the use of advanced technologies, researchers are developing a clearer understanding of pathogens, disease, and host immunity.
Research Area Type
Disciplines & Approaches

Finding Function for Noncoding RNAs Using a New Kind of CRISPR

Next-generation Genetic Tools Reveal New Aspects of Enterovirus Evolution

NIAID Now |

NIAID Scientists Explore Pathways of Viral Evolution

Viruses are known to evolve quickly, in part because one generation of viral growth occurs in just minutes—an instant compared to the decades taken for a human generation to occur. This evolution happens at a vast scale, too. There are more viruses on the planet than stars in the universe. That’s trillions of trillions of viruses, all evolving at breakneck speed—and yet, researchers have found that viruses often evolve to arrive at similar genetic features. NIAID scientists recently developed new tools to understand this process in an important group of viruses called enteroviruses, which are responsible for several dangerous diseases, including polio; hand, foot, and mouth disease (HFMD); and acute flaccid myelitis (AFM). Their findings have implications for the evolution of other viral pathogens, as well.

The enterovirus that causes polio, Poliovirus, may be the most well-known. It infects the nervous system, leading to paralysis and death in severe cases. Although vaccination against polio has resulted in eradication of the virus from many parts of the world, the virus continues to emerge in some places, posing a threat to public health. HFMD is caused by different enteroviruses from a group often referred to as non-polio enteroviruses, including enterovirus A71 (EV-A71) and coxsackie virus A6 (CV-A6). HFMD is very contagious and often results in a fever, sore throat, and rash, with symptoms more commonly occurring in children than adults. Although uncommon, HFMD can result in serious complications, and so large outbreaks can raise public health concerns. In rare cases, non-polio enteroviruses such as EV-A71 and EV-D68 can also lead to AFM, a dangerous disorder of the nervous system that can result in permanent impairment. Despite the risks they pose, many enteroviruses and the diseases they cause are not well understood. It’s important for scientists to uncover how enteroviruses grow and evolve so they can develop new countermeasures against these diseases.

Patrick Dolan, Ph.D., chief of the Quantitative Virology and Evolution Unit in the Division of Intramural Research, is investigating aspects of enterovirus evolution. His research group developed a new method called SEARCHLIGHT (short for scRNA-seq–enabled acquisition of mRNA and consensus haplotypes linking individual genotypes and host transcriptomes). The method homes in on individual viruses within a rapidly evolving viral population. Using cutting-edge technology, the scientists examined the communities of viruses in single cells during viral infection. This method allows for the exploration of the concept of “viral quasi-species”—a term coined by scientists to describe how populations of viruses rapidly evolve when faced with new environmental pressures. The researchers observed how, in specific conditions, viral populations explore their “genetic neighborhood”—the possible ways they could adapt—through mutation to find more successful genetic strategies. In addition, they observed how EV-D68 and EV-A71, two distantly related members of the enterovirus family, followed common routes of evolution under similar conditions, suggesting that the routes viruses travel to explore their genetic neighborhood are shaped by common features of the viruses. Insights from this research may allow researchers to predict how new viral variants emerge and develop strategies to counter them.

To further explore features of enterovirus evolution, Dr. Dolan’s team used an innovative method to map all the sites of the genome known to foster insertions and deletions, or InDels. InDels are major evolutionary events in which short genetic sequences can be removed or added, as opposed to single substitutions in the genetic sequence, which are minor events that generally have more modest effects on gene function. The team examined tens of thousands of mutations in EV-A71, finding that InDels were only tolerated at specific hotspots, many of which appear to be critical for adaptions in viral function and immune evasion. For instance, the researchers observed many InDels in the regions of the genome dedicated to forming the viral capsid—the outer shell of the virus that interacts with the body’s machinery to enter cells, as well as triggering an immune response. This suggests that InDels in this region provide a mechanism for the virus to adapt new ways to infect cells and trick the immune system, which are critical functions for viral propagation. Based on these findings, InDels contribute significantly to the evolution and diversification of viruses. This new map of InDel sites may provide novel avenues for investigation of viral functions and interventions against them.

These studies demonstrate the power of advanced genetic technology to explore important questions in enterovirus evolution. Because enteroviruses have genetic similarities to many other viruses, this research has further implications towards discovering mechanisms of adaptation in a range of pathogens. A deepened understanding of viral evolution will provide researchers with new ways to develop targets for vaccines, therapeutics, and other countermeasures. Additionally, this research highlights the importance of investing in basic research to into how viruses adapt and function, fostering a body of knowledge researchers can draw upon for the development of interventions against infectious diseases. 

 

References:

Contact Information

Contact the NIAID Media Team.

301-402-1663
niaidnews@niaid.nih.gov

Search NIAID Blog

Study: AI Could Transform How Hospitals Produce Quality Reports

Media Type
Article
Publish or Event Date
Research Institution
University of California San Diego School of Medicine
Short Title
Study: AI Could Transform How Hospitals Produce Quality Reports
Content Coordinator
Content Manager

Single Mutation in H5N1 Influenza Surface Protein Could Enable Easier Human Infection

A single modification in the protein found on the surface of the highly pathogenic avian influenza (HPAI) H5N1 influenza virus currently circulating in U.S. dairy cows could allow for easier transmission among humans, according to new research funded by the National Institutes of Health (NIH) and published today in the journal Science. The study results reinforce the need for continued, vigilant surveillance and monitoring of HPAI H5N1 for potential genetic changes that could make the virus more transmissible in humans.

Contact

Submit a Media Request

Contact the NIAID News & Science Writing Branch.

301-402-1663
niaidnews@niaid.nih.gov
All Media Contacts

Philip P. Adams, Ph.D.

Contact: philip.adams@nih.gov

Education:

Ph.D., 2017, Biomedical Sciences, University of Central Florida, FL
B.S., 2012, Biology, Summa Cum Laude, West Virginia Wesleyan College, WV

Headshot of Philip P. Adams, Ph.D.

NIH Awards $7.5 Million to Ankur Singh for Pioneering Human Immune Organoid Research

Media Type
Article
Publish or Event Date
Research Institution
Georgia Tech
Short Title
NIH Awards $7.5 Million to Ankur Singh for Pioneering Human Immune Organoid Research
Content Coordinator
Content Manager